Morgan Stanley

Selected news for the capital firm - Morgan Stanley, collected since 10/2017. Recent stories appear in dispatchtribunal.com and Dakota Financial News. This capital firm shares healthcare news with Medical Research, CVS Health, CVS, Pfizer, Wolfe Research and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/10/2021 Adaptive Biotechnologies (NASDAQ:ADPT) PT Lowered to $55.00 at Morgan Stanley dispatchtribunal.com US Crude Prices Plummet 4% as Russia and OPEC Consider Easing CapsAdaptive Biotechnologies (NASDAQ:ADPT) had its target price trimmed by Morgan Stanley from $60.00 to $55.00 in a research report report published on Friday morning, PriceTargets.com reports. The firm currently has an equal weight rating on the stock.Several other equities research analysts have also commented on ADPT. The Goldman Sachs Group restated a neutral rating and set ...
5/8/2021 Eli Lilly and (NYSE:LLY) Price Target Lowered to $227.00 at Barclays dispatchtribunal.com ... on Friday, January 22nd. Truist Securities upped their target price on Eli Lilly and from $215.00 to $225.00 and gave the stock a buy rating in a research note on Monday, March 22nd. Finally, Morgan Stanley lowered their target price on Eli Lilly and from $217.00 to $207.00 and set an overweight rating on the stock in a research note on Tuesday. Two analysts have rated the stock with a ...
5/8/2021 IQVIA Holdings Inc. (NYSE:IQV) Stake Raised by Handelsbanken Fonder AB - American Banking News American Banking News ... stake in IQVIA by 7.9% in the 4th quarter. Alliancebernstein L.P. now owns 6,303,471 shares of the medical research company’s stock worth $1,129,393,000 after purchasing an additional 461,873 shares in the last quarter. Morgan Stanley increased its stake in IQVIA by 19.1% in the 4th quarter. Morgan Stanley now owns 3,020,834 shares of the medical research company’s stock worth $541,242,000 after purchasing an additional 483,960 shares in the ...
5/8/2021 IQVIA Holdings Inc. (NYSE:IQV) Stake Raised by Handelsbanken Fonder AB Mayfield Recorder ... stake in IQVIA by 7.9% in the 4th quarter. Alliancebernstein L.P. now owns 6,303,471 shares of the medical research company’s stock worth $1,129,393,000 after purchasing an additional 461,873 shares in the last quarter. Morgan Stanley increased its stake in IQVIA by 19.1% in the 4th quarter. Morgan Stanley now owns 3,020,834 shares of the medical research company’s stock worth $541,242,000 after purchasing an additional 483,960 shares in the ...
5/8/2021 Investors Purchase Large Volume of Call Options on SPDR S&P Biotech ETF (NYSEARCA:XBI) - Transcript Daily transcriptdaily.com ... the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 14,334,000 shares of the exchange traded fund’s stock valued at $2,017,941,000 after buying an additional 12,000,000 shares during the last quarter. Morgan Stanley grew its stake in SPDR S&P Biotech ETF by 34.3% in the fourth quarter. Morgan Stanley now owns 15,424,655 shares of the exchange traded fund’s stock valued at $2,171,483,000 after purchasing an ...
5/8/2021 Stock Traders Buy High Volume of Call Options on SPDR S&P Biotech ETF (NYSEARCA:XBI) - Stock Observer thestockobserver.com ... the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 14,334,000 shares of the exchange traded fund’s stock valued at $2,017,941,000 after buying an additional 12,000,000 shares in the last quarter. Morgan Stanley increased its stake in SPDR S&P Biotech ETF by 34.3% during the 4th quarter. Morgan Stanley now owns 15,424,655 shares of the exchange traded fund’s stock worth $2,171,483,000 after buying an additional ...
5/8/2021 Ionis Pharmaceuticals (NASDAQ:IONS) Shares Down 9.3% After Earnings Miss The Markets Daily ... was down 15.8% on a year-over-year basis. During the same period in the prior year, the business earned ($0.35) EPS. Get Ionis Pharmaceuticals alerts:Several analysts have weighed in on IONS shares. Morgan Stanley cut their target price on Ionis Pharmaceuticals from $38.00 to $35.00 and set an “underweight” rating on the stock in a research note on Thursday. TheStreet lowered Ionis Pharmaceuticals from a “c” ...
5/8/2021 Zacks Investment Research Downgrades Outset Medical (NASDAQ:OM) to Hold baseballnewssource.com ... in on OM. Wells Fargo & Company initiated coverage on shares of Outset Medical in a report on Monday, April 26th. They issued an “overweight” rating and a $63.00 price target on the stock. Morgan Stanley increased their target price on Outset Medical from $58.00 to $60.00 and gave the stock an “equal weight” rating in a research note on Thursday. Four analysts have rated the stock with a ...
5/8/2021 Q2 2021 EPS Estimates for Globus Medical, Inc. (NYSE:GMED) Increased by SVB Leerink | Daily Political Daily Political ... was up 19.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.29 EPS. A number of other analysts have also issued reports on the stock. Morgan Stanley lifted their price objective on shares of Globus Medical from $72.00 to $77.00 and gave the company an “equal weight” rating in a research note on Wednesday. Zacks Investment Research lowered Globus Medical ...
5/8/2021 Equities Analysts Set Expectations for Pfizer Inc.'s FY2021 Earnings (NYSE:PFE) baseballnewssource.com ... Fitzgerald analyst L. Chen forecasts that the biopharmaceutical company will post earnings of $3.55 per share for the year. Get Pfizer alerts:Several other research analysts have also recently issued reports on the company. Morgan Stanley dropped their price objective on Pfizer from $40.00 to $38.00 and set an “equal weight” rating on the stock in a research note on Friday, January 29th. TheStreet raised Pfizer from a “c ...
5/8/2021 Arrow Financial Corp Raises Stock Holdings in Pfizer Inc. (NYSE:PFE) dispatchtribunal.com ... of its most recent SEC filing.A number of other hedge funds have also recently modified their holdings of PFE. Norges Bank purchased a new stake in Pfizer in the fourth quarter worth $2,219,532,000. Morgan Stanley grew its stake in Pfizer by 16.4% in the fourth quarter. Morgan Stanley now owns 53,610,111 shares of the biopharmaceutical company’s stock worth $1,973,389,000 after purchasing an additional 7,540,245 shares during the period ...
5/8/2021 Bristlecone Advisors LLC Lowers Stock Holdings in Pfizer Inc. (NYSE:PFE) slatersentinel.com ... other institutional investors and hedge funds have also recently added to or reduced their stakes in PFE. Norges Bank purchased a new position in shares of Pfizer during the 4th quarter valued at $2,219,532,000. Morgan Stanley increased its holdings in Pfizer by 16.4% in the 4th quarter. Morgan Stanley now owns 53,610,111 shares of the biopharmaceutical company’s stock valued at $1,973,389,000 after acquiring an additional 7,540,245 shares during the ...
5/8/2021 Ortho Clinical Diagnostics (NASDAQ:OCDX) Hits New 1-Year High After Analyst Upgrade rivertonroll.com ... on the stock. Citigroup started coverage on shares of Ortho Clinical Diagnostics in a research note on Monday, February 22nd. They issued a “buy” rating and a $20.00 target price for the company. Morgan Stanley upped their target price on shares of Ortho Clinical Diagnostics from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Thursday. UBS Group started coverage on shares of ...
5/8/2021 Inovalon (NASDAQ:INOV) Stock Rating Lowered by Zacks Investment Research - Ticker Report Ticker Report ... serves health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings, Inc. is headquartered in Bowie, Maryland. “Get Inovalon alerts: A number of other research firms also recently issued reports on INOV. Morgan Stanley boosted their price target on shares of Inovalon from $23.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, February 4th. KeyCorp boosted their price target ...
5/8/2021 JPMorgan Chase & Co. Reiterates “Neutral” Rating for Wolters Kluwer (OTCMKTS:WTKWY) - Ticker Report Ticker Report Wolters Kluwer (OTCMKTS:WTKWY) ‘s stock had its “neutral” rating reiterated by analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday, The Fly reports.WTKWY has been the subject of a number of other reports. Morgan Stanley reaffirmed an “overweight” rating on shares of Wolters Kluwer in a research report on Tuesday, March 2nd. Barclays reissued an “equal weight” rating on shares of ...
5/8/2021 Wolters Kluwer (OTCMKTS:WTKWY) Receives ‚ÄúNeutral‚Äù Rating from JPMorgan Chase & Co. - Watch List News watchlistnews.com ... Äúequal weight‚Äù rating on shares of Wolters Kluwer in a research note on Thursday. Berenberg Bank reaffirmed a ‚Äúhold‚Äù rating on shares of Wolters Kluwer in a report on Wednesday, March 3rd. Morgan Stanley reaffirmed an ‚Äúoverweight‚Äù rating on shares of Wolters Kluwer in a report on Tuesday, March 2nd. Zacks Investment Research downgraded shares of Wolters Kluwer from a ‚Äúhold‚Äù rating to a ‚Äúsell‚Äù ...
5/8/2021 Credit Suisse Group Reiterates Outperform Rating for Wolters Kluwer (OTCMKTS:WTKWY) baseballnewssource.com ... Äúoutperform‚Äù rating reiterated by investment analysts at Credit Suisse Group in a report released on Thursday, The Fly reports.A number of other equities analysts have also recently issued reports on the company. Morgan Stanley restated an ‚Äúoverweight‚Äù rating on shares of Wolters Kluwer in a report on Tuesday, March 2nd. The Goldman Sachs Group upgraded Wolters Kluwer from a ‚Äúsell‚Äù rating to a ‚Äúneutral‚Äù rating ...
5/8/2021 Wolters Kluwer (OTCMKTS:WTKWY) Stock Rating Reaffirmed by Barclays slatersentinel.com ... in a research note on Wednesday, March 3rd. Zacks Investment Research cut shares of Wolters Kluwer from a “hold” rating to a “sell” rating in a research note on Thursday, April 8th. Morgan Stanley restated an “overweight” rating on shares of Wolters Kluwer in a research note on Tuesday, March 2nd. Finally, The Goldman Sachs Group upgraded shares of Wolters Kluwer from a “sell” rating to ...
5/8/2021 Q2 2021 EPS Estimates for Globus Medical, Inc. Boosted by Analyst (NYSE:GMED) rivertonroll.com ... of $0.40. SVB Leerink has a “Outperform” rating and a $81.00 price objective on the stock. Get Globus Medical alerts:A number of other research firms have also recently weighed in on GMED. Morgan Stanley upped their price target on shares of Globus Medical from $72.00 to $77.00 and gave the stock an “equal weight” rating in a research note on Wednesday. Canaccord Genuity upped their target price ...
5/8/2021 CommScope (NASDAQ:COMM) Upgraded at Credit Suisse Group - Transcript Daily transcriptdaily.com Credit Suisse Group upgraded shares of CommScope (NASDAQ:COMM) from a neutral rating to an outperform rating in a research note published on Tuesday, The Fly reports.A number of other equities research analysts have also recently weighed in on the company. Morgan Stanley lifted their price objective on CommScope from $16.00 to $18.00 and gave the company an overweight rating in a research note on Monday, January 25th. TheStreet ...